Yuan Zhi
Stock Analyst at B. Riley Securities
(1.05)
# 3,728
Out of 4,876 analysts
25
Total ratings
37.5%
Success rate
-16.7%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CATX Perspective Therapeutics | Maintains: Buy | $9 → $12 | $3.76 | +219.15% | 3 | Jun 23, 2025 | |
| RDNT RadNet | Initiates: Buy | $69 | $57.12 | +20.80% | 1 | Jun 13, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.2 → $1 | $0.74 | +34.84% | 2 | May 15, 2025 | |
| MIR Mirion Technologies | Maintains: Buy | $19 → $17 | $21.71 | -21.70% | 2 | Apr 16, 2025 | |
| RADX Radiopharm Theranostics | Initiates: Buy | $15 | $4.72 | +217.88% | 1 | Mar 12, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $16 → $8 | $5.01 | +59.68% | 2 | Nov 11, 2024 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $4.76 | +278.15% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $7.41 | +102.43% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $1.23 | +143.90% | 1 | May 15, 2024 | |
| AZTA Azenta | Maintains: Buy | $61 → $79 | $30.59 | +158.25% | 3 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $1.42 | +1,026.76% | 4 | Dec 11, 2023 |
Perspective Therapeutics
Jun 23, 2025
Maintains: Buy
Price Target: $9 → $12
Current: $3.76
Upside: +219.15%
RadNet
Jun 13, 2025
Initiates: Buy
Price Target: $69
Current: $57.12
Upside: +20.80%
Hyperfine
May 15, 2025
Maintains: Buy
Price Target: $1.2 → $1
Current: $0.74
Upside: +34.84%
Mirion Technologies
Apr 16, 2025
Maintains: Buy
Price Target: $19 → $17
Current: $21.71
Upside: -21.70%
Radiopharm Theranostics
Mar 12, 2025
Initiates: Buy
Price Target: $15
Current: $4.72
Upside: +217.88%
Tango Therapeutics
Nov 11, 2024
Maintains: Buy
Price Target: $16 → $8
Current: $5.01
Upside: +59.68%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $4.76
Upside: +278.15%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $7.41
Upside: +102.43%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $1.23
Upside: +143.90%
Azenta
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $30.59
Upside: +158.25%
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.42
Upside: +1,026.76%